BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Българска асоциация по патология - ECPv5.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Българска асоциация по патология
X-ORIGINAL-URL:https://bpa-pathology.com
X-WR-CALDESC:Събития за Българска асоциация по патология
BEGIN:VTIMEZONE
TZID:Europe/Sofia
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Sofia:20210204T160000
DTEND;TZID=Europe/Sofia:20210204T170000
DTSTAMP:20260423T224546
CREATED:20210202T095149Z
LAST-MODIFIED:20210202T095149Z
UID:3080-1612454400-1612458000@bpa-pathology.com
SUMMARY:ddPCR for the Determination of MSI Status in Patients with Cancer
DESCRIPTION:Microsatellite instability (MSI) status is routinely assessed in patients with colorectal and endometrial cancers as it contributes to Lynch syndrome initial screening\, tumour prognosis\, and selecting patients for immunotherapy. Standard reference methods recommended for MSI/dMMR (deficient MisMatch Repair) testing consist of IHC and PCR-based assays\, however\, novel molecular-based techniques are emerging. During this webinar\, Dr Alexandre Harlé will present the results of his performance evaluation of the Bio-Rad ddPCR assay.
URL:https://bpa-pathology.com/event/ddpcr-for-the-determination-of-msi-status-in-patients-with-cancer/
END:VEVENT
END:VCALENDAR